Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
Reads0
Chats0
TLDR
Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.Abstract:
In recent years, the development of nanoparticles has expanded into a broad range of clinical applications. Nanoparticles have been developed to overcome the limitations of free therapeutics and navigate biological barriers - systemic, microenvironmental and cellular - that are heterogeneous across patient populations and diseases. Overcoming this patient heterogeneity has also been accomplished through precision therapeutics, in which personalized interventions have enhanced therapeutic efficacy. However, nanoparticle development continues to focus on optimizing delivery platforms with a one-size-fits-all solution. As lipid-based, polymeric and inorganic nanoparticles are engineered in increasingly specified ways, they can begin to be optimized for drug delivery in a more personalized manner, entering the era of precision medicine. In this Review, we discuss advanced nanoparticle designs utilized in both non-personalized and precision applications that could be applied to improve precision therapies. We focus on advances in nanoparticle design that overcome heterogeneous barriers to delivery, arguing that intelligent nanoparticle design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.read more
Citations
More filters
Journal ArticleDOI
An Apoptotic Body‐based Vehicle with Navigation for Photothermal‐Immunotherapy by Precise Delivery and Tumor Microenvironment Regulation
TL;DR: In this paper , an IR820-conjugated apoptotic body loaded with R848 nanoparticles was developed for precise tumor delivery and photothermal-immunotherapy by IR820.
Journal ArticleDOI
Controlled Release of TGF-β3 for Effective Local Endogenous Repair in IDD Using Rat Model
Lifan Zhu,Yan-Jun Yang,ZhanJun Yan,Jincai Zeng,Fengbiao Weng,Yuhui Shi,Pengcheng Shen,Ling Liu,Huilin Yang +8 more
TL;DR: In this paper , an intelligent biodegradable nanoplatform using hollow manganese dioxide (H-MnO2) was developed to modulate the degenerative microenvironment and release transforming growth factor beta-3 (TGF-β3), which may achieve good long-term therapeutic effects on needle puncture-induced intervertebral disc (IVD) degeneration.
Journal ArticleDOI
Near Infrared Fluorescent Nanostructure Design for Organic/Inorganic Hybrid System.
TL;DR: In this paper, the authors present an approach for employing the polarity and vibrational energy of ions and molecules that surround the luminescence centers for the development of such hybrid nanostructures.
Journal ArticleDOI
Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature.
Huimin Kong,Kevin Yi,Chunxiong Zheng,Yeh-Hsing Lao,Huicong Zhou,Hon Fai Chan,Haixia Wang,Yu Tao,Mingqiang Li +8 more
TL;DR: The membrane fusion enables cell surface modification through lipid diffusion and mixing, providing a tool for direct cell membrane engineering, and the present challenges and opportunities are concluded, providing insights in the future research of membrane-fusogenic particles.
Journal ArticleDOI
Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast
TL;DR: Man-LPHFNPs@Roflumilast show high cytocompatibility toward human bronchial epithelium cells and macrophages and are uptaken by the latter through an active mannose-mediated targeting process, which confers mucus-penetrating properties.
References
More filters
Journal ArticleDOI
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita,Seung-Yeol Park,Tadashi Nishio,Koki Kamizaki,ZhiChao Wang,Kota Tamada,Toru Takumi,Ryuju Hashimoto,Hiroki Otani,Gregory J. Pazour,Victor W. Hsu,Yasuhiro Minami +11 more
TL;DR: It is found that intraflagellar transport 20 mediates the ability of Ror2 signaling to induce the invasiveness of tumors that lack primary cilia, and IFT20 regulates the nucleation of Golgi-derived microtubules by affecting the GM130-AKAP450 complex.
Journal ArticleDOI
Double-slit photoelectron interference in strong-field ionization of the neon dimer.
Maksim Kunitski,Nicolas Eicke,Pia Huber,Jonas Köhler,S. Zeller,J. Voigtsberger,Nikolai Schlott,K. Henrichs,H. Sann,Florian Trinter,Lothar Ph. H. Schmidt,Anton Kalinin,Markus Schöffler,Till Jahnke,Manfred Lein,Reinhard Dörner +15 more
TL;DR: The authors show the double-slit interference effect in the strong-field ionization of neon dimers by employing COLTRIMS method to record the momentum distribution of the photoelectrons in the molecular frame.
Journal ArticleDOI
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman,Axel Hauschild,Caroline Robert,John B. A. G. Haanen,Paolo A. Ascierto,James Larkin,Reinhard Dummer,Claus Garbe,Alessandro Testori,Michele Maio,David W. Hogg,Paul Lorigan,Céleste Lebbé,Thomas Jouary,Dirk Schadendorf,Antoni Ribas,Jeffrey A. Sosman,John M. Kirkwood,Brigitte Dréno,K. B. Nolop,Jiang Li,B. Nelson,Jeannie Hou,Richard J. Lee,Keith T. Flaherty,Grant A. McArthur +25 more
TL;DR: Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation in a phase 3 randomized clinical trial.
Journal ArticleDOI
Principles of nanoparticle design for overcoming biological barriers to drug delivery
TL;DR: By successively addressing each of the biological barriers that a particle encounters upon intravenous administration, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
Journal ArticleDOI
A New Initiative on Precision Medicine
TL;DR: A research initiative that aims to accelerate progress toward a new era of precision medicine, with a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.
Related Papers (5)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more